Figure 5 from The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with <i>KRAS</i><sup>G12C</sup> Inhibitors in Preclinical Models
Work
Year: 2025
Type: preprint
Abstract: <p>Combination of azenosertib with <i>KRAS</i><sup>G12C</sup> inhibitors <i>in vivo</i> increases the depth and duration of TGI in NSCLC models sensitive to &... more
Cites:
Cited by:
Related to: 10
Citation percentile (by year/subfield):
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze